CSF1 is required for survival of immunosuppressive TAMs that promote angiogenesis and tumor metastasis and studies in mouse models of breast cancer have shown TAM recruitment into the tumor due to CSF-1/CSF-1R signaling [58, 59]. This evidence concerns the gene CSF1 and breast carcinoma.